Details for New Drug Application (NDA): 061454
✉ Email this page to a colleague
NDA 061454 describes DICLOXACILLIN SODIUM, which is a drug marketed by Aurobindo Pharma, Chartwell Rx, Teva, and Apothecon, and is included in four NDAs. It is available from six suppliers. Additional details are available on the DICLOXACILLIN SODIUM profile page.
The generic ingredient in DICLOXACILLIN SODIUM is dicloxacillin sodium. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
The generic ingredient in DICLOXACILLIN SODIUM is dicloxacillin sodium. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
Summary for 061454
| Tradename: | DICLOXACILLIN SODIUM |
| Applicant: | Chartwell Rx |
| Ingredient: | dicloxacillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 061454
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 125MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 500MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
